A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features. 2010

C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
Dept. of Infectious Diseases and Tropical Medicine, University La Sapienza Rome, Rome, Italy.

BACKGROUND The aim of this paper was to enlarge the available knowledge on clinical and etiological aspects of patients affected by spondylodiscitis. METHODS All patients with spondylodiscitis admitted between January 2001 and December 2007 at the 1,300-bed University Hospital "Policlinico Umberto I" of Rome, Italy, were followed. Demographic characteristics, underlying diseases, invasive procedures, imaging studies, isolated microorganisms, treatment, complications, and outcome were recorded. RESULTS Eighty-one patients of mean age 57.7 +/- 14.7 years with lumbosacral (72.8%), thoracic (14.8%), and cervical tract (12.3%) site of infection were included, of which 38 developed community-acquired (CA) spondylodiscitis and 43 developed hospital-acquired (HA) spondylodiscitis. Underlying disease was present in 49.4% of patients. HA spondylodiscitis was diagnosed earlier (46.8 +/- 49.7 days) than CA spondylodiscitis (65.0 +/- 55.4 days) (P < 0.05). The most frequently isolated microorganisms were Staphylococcus aureus (28 strains, 43.1%), coagulase-negative staphylococci (CNS) (eight strains, 12.3%), Pseudomonas aeruginosa (eight strains, 12.3%), and three methicillin-resistant S. aureus (MRSA) strains were isolated in CA spondylodiscitis. Fungi and yeasts, isolated in six patients, represented 9.2% of all strains but 17.6% when considering only HA spondylodiscitis. Over 85% of patients were managed by conservative treatment alone, and the treatment time depended on clinical and laboratory evidence. Poor outcome was recorded in 12 (14.8%) patients, and was associated with neurological deficit symptoms (relative risk [RR] 2.87; 95% confidence interval [CI] 1.02-8.07; P < 0.05) and the time between diagnosis and the onset of symptoms > or = 60 days (RR 2.65; 95% CI 0.92-7.59; P < 0.05). CONCLUSIONS Infectious spondylodiscitis affects most frequently the elderly population, who are more exposed to healthcare contacts. Consequently, the infection etiology includes a growing proportion of multi-resistant bacteria and fungi.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
January 2013, Urologia,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
April 2012, European review for medical and pharmacological sciences,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
January 1981, Acta medica Scandinavica,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
May 2016, Acta medica portuguesa,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
August 2001, Archives of disease in childhood,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
July 2005, The Journal of bone and joint surgery. British volume,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
March 1990, East African medical journal,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
June 2024, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
June 1990, European journal of epidemiology,
C D'Agostino, and L Scorzolini, and A P Massetti, and M Carnevalini, and G d'Ettorre, and M Venditti, and V Vullo, and G B Orsi
December 2011, Journal of medical virology,
Copied contents to your clipboard!